One of the most intensively investigated molecular targets in oncology proves its therapeutic worth for thyroid eye disease.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E. IGF-1R drugs travel from cancer cradle to Graves’. Nat Biotechnol 38, 385–388 (2020). https://doi.org/10.1038/s41587-020-0481-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0481-8
- Springer Nature America, Inc.